{"gene":"GRK4","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1996,"finding":"GRK4 is a functional protein kinase capable of phosphorylating agonist-occupied, purified beta2-adrenergic receptor in vitro, and all four splice variants incorporate [3H]palmitate (palmitoylation). GRK4 augments desensitization of the rat luteinizing hormone/chorionic gonadotropin receptor upon coexpression in HEK293 cells.","method":"In vitro kinase assay with purified beta2-adrenergic receptor; [3H]palmitate incorporation; coexpression in HEK293 cells with functional desensitization readout","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus receptor desensitization in cells, multiple isoforms tested, original characterization paper","pmids":["8626439"],"is_preprint":false},{"year":1997,"finding":"GRK4alpha, but not GRK4beta, -gamma, or -delta, phosphorylates rhodopsin in an agonist-dependent manner. GRK4alpha kinase activity is inhibited by Ca2+/calmodulin (IC50 ~80 nM) via a direct interaction; the other three isoforms do not interact with calmodulin. GRK4gamma is the only detectable isoform in human sperm. GRK4 is localized to acrosomal membranes and outer mitochondrial membranes of spermatozoa.","method":"Rhodopsin phosphorylation assay; CaM-Sepharose 4B pulldown; immunochemical and ultrastructural (electron microscopy) localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay with isoform-specific comparisons, direct binding pulldown, structural localization by electron microscopy, multiple orthogonal methods","pmids":["9092566"],"is_preprint":false},{"year":1998,"finding":"Rat GRK4A and GRK4B are both functional protein kinases, as demonstrated by rhodopsin phosphorylation. GRK4A mRNA predominates in leptotene to late pachytene primary spermatocytes and round spermatids; GRK4B mRNA is enriched ~20-fold in renal outer medulla compared to testis, indicating isoform-specific tissue distribution.","method":"Rhodopsin phosphorylation assay; in situ hybridization; quantitative RT-PCR","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — kinase activity confirmed by in vitro assay, tissue distribution by two orthogonal methods (ISH + qRT-PCR), single lab","pmids":["9607785"],"is_preprint":false},{"year":1998,"finding":"GRK4 delta (but not GRK2) did not significantly facilitate sequestration of muscarinic m1–m5 receptors in COS-7 cells, with the partial exception that GRK4 delta tended to facilitate m2 receptor sequestration. In BHK-21 cells, GRK4 delta facilitated sequestration of m2 but not m3 receptors.","method":"Radioligand binding ([3H]N-methylscopolamine) sequestration assay in COS-7 and BHK-21 cells with GRK coexpression","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based receptor sequestration assay with functional readout, multiple receptor subtypes and cell lines tested, single lab","pmids":["9495886"],"is_preprint":false},{"year":2000,"finding":"GRK4 mediates homologous desensitization of the mGlu1 metabotropic glutamate receptor in cerebellar Purkinje cells. GRK4 kinase activity is required: agonist-dependent phosphorylation of mGlu1a was demonstrated, and antisense reduction of GRK4 in Purkinje cells impaired receptor desensitization. GRK4 redistributes and colocalizes with mGlu1 receptor upon agonist exposure and internalization.","method":"Coexpression in HEK293 cells with functional signaling assay; receptor phosphorylation assay; antisense knockdown in primary Purkinje cells; confocal colocalization imaging","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (phosphorylation assay, antisense KD with phenotypic rescue, colocalization), replicated across heterologous and primary cells","pmids":["11099476"],"is_preprint":false},{"year":2003,"finding":"GRK4 mediates agonist-promoted desensitization of the heterodimeric GABA(B) receptor in cerebellar granule cells via a phosphorylation-independent mechanism. siRNA knockdown of GRK4 strongly inhibited desensitization; GRK4 mutants deleted of their kinase domain could still promote desensitization; no ligand-induced receptor phosphorylation was detected.","method":"siRNA knockdown in cerebellar granule cells; transfection of kinase-dead/domain-deleted GRK4 mutants in HEK293 cells; functional desensitization assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — siRNA KD with rescue by transfection, domain-deletion mutagenesis establishing phosphorylation independence, multiple cell systems, orthogonal methods","pmids":["12881416"],"is_preprint":false},{"year":2004,"finding":"GRK4, unlike GRK2, does not interact with Galphaq (neither in vitro nor in cells) and therefore does not inhibit Galphaq-dependent signaling, distinguishing the modulatory activities of these two kinase subfamilies.","method":"In vitro binding assay; cell-based signaling assay measuring Galphaq-dependent activity with GRK N-terminal domain constructs","journal":"Methods in enzymology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro binding and cell-based assay, mechanistically informative negative result for GRK4/Galphaq interaction, single lab","pmids":["15488187"],"is_preprint":false},{"year":2007,"finding":"GRK4 desensitizes GABA(B) receptor-mediated signaling by forming a direct protein complex with the GB2 subunit at the plasma membrane. Upon GABA(B) receptor activation, GRK4 translocates from cytosol to plasma membrane. FRET analysis and co-immunoprecipitation confirmed GRK4–GB2R complex formation. GRK5 also forms this complex; GRK2, GRK3, and GRK6 do not.","method":"FRET (GRK4-Cerulean / GB2R-Venus); co-immunoprecipitation/Western blot; live-cell imaging of GRK4 translocation; Xenopus oocyte electrophysiology; BHK cell transfection","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reciprocal FRET + co-IP confirming complex, translocation imaging, functional electrophysiology, multiple orthogonal methods in same study","pmids":["17013811"],"is_preprint":false},{"year":2009,"finding":"GRK4 (specifically GRK4-gamma and GRK4-alpha isoforms) co-immunoprecipitates and co-localizes with the dopamine D3 receptor in human proximal tubule cells and rat kidney. Agonist activation initiates GRK4–D3R interaction at the cell membrane and promotes it intracellularly. GRK4-gamma and GRK4-alpha mediate 3- and 2-fold increases in phosphorylation of agonist-activated D3R, respectively. GRK4 knockdown abolished D3R-stimulated p44/42 phosphorylation and mitogenesis.","method":"Co-immunoprecipitation; bimolecular fluorescence complementation (BiFC) + confocal microscopy; RNAi knockdown; kinase activity inhibition with heparin; receptor phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, BiFC interaction assay, RNAi KD with signaling readout, isoform-specific phosphorylation, multiple orthogonal methods","pmids":["19520868"],"is_preprint":false},{"year":2013,"finding":"GRK4 interacts directly with the angiotensin II type 1 receptor (AT1R) in vascular smooth muscle cells. The GRK4gamma A142V variant increases AT1R mRNA and protein expression via the NF-κB pathway (with greater NF-κB binding to the AT1R promoter), decreases AT1R phosphorylation (reducing degradation), and enhances AT1R-mediated intracellular calcium responses and angiotensin II-mediated vasoconstriction in transgenic mice.","method":"Co-immunoprecipitation; heterologous expression of GRK4γ 142V in A10 cells; NF-κB reporter/ChIP assay; calcium imaging; transgenic mouse model; aortic vasoconstriction assay","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP establishing interaction, NF-κB ChIP, transgenic mouse validation, multiple orthogonal methods across cell and animal models","pmids":["24218433"],"is_preprint":false},{"year":2013,"finding":"The transcription factor c-Myc binds the GRK4 promoter and positively regulates GRK4 protein expression in human renal proximal tubule cells. Angiotensin II (via AT1R) increases phospho-c-Myc and subsequently GRK4 expression, which then uncouples D1R from adenylyl cyclase. c-Myc inhibitor 10074-G5 or AT1R blockade with losartan restored D1R coupling.","method":"Chromatin immunoprecipitation (ChIP) for c-Myc at GRK4 promoter; pharmacological inhibition; Western blot for phospho-c-Myc and GRK4; adenylyl cyclase coupling assay","journal":"Hypertension","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating c-Myc binding to GRK4 promoter, pharmacological rescue, single lab with two orthogonal methods","pmids":["23509080"],"is_preprint":false},{"year":2015,"finding":"FMRP (Fragile X Mental Retardation Protein) binds GRK4 mRNA via a specific stem-loop domain (G4RIF) in the 3' region through its C-terminal domain, and negatively regulates GRK4 translation in cerebellum. GRK4 protein (but not mRNA) is increased in Fmr1-null cerebellum, indicating translational repression.","method":"In vitro RNA binding assay; in vivo RIP (RNA immunoprecipitation); Western blot and qPCR in Fmr1 knockout mouse cerebellum; reporter assay with G4RIF domain","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo binding confirmed, protein/mRNA discordance in KO tissue, single lab with two orthogonal methods","pmids":["26250109"],"is_preprint":false},{"year":2015,"finding":"GRK4 subfamily members (GRK5/6, closely related to GRK4) phosphorylate inactive (unactivated) GPCRs, including beta2-adrenergic and M2 muscarinic receptors, in an agonist-independent manner, and this phosphorylation enhances arrestin recruitment. GRK4 subfamily differs from GRK2/3 subfamily in this respect.","method":"In vitro phosphorylation assay; arrestin recruitment assay; mutagenesis to exclude constitutive receptor activity; membrane-association controls","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro assay with mutagenesis controls, but GRK4 itself was not directly tested (GRK5/6 as proxies), single lab","pmids":["25770216"],"is_preprint":false},{"year":2020,"finding":"GRK4 phosphorylates and desensitizes the adiponectin receptor-1 (AdipoR1) in renal proximal tubule cells, uncoupling it from Gαi and impairing adiponectin-mediated inhibition of Na+-K+-ATPase activity. GRK4 transgenic (hyperphosphorylating variant) mice replicate impaired adiponectin-mediated natriuresis; siRNA-mediated GRK4 knockdown in SHR restores adiponectin-mediated sodium excretion.","method":"GRK4 transgenic mouse model; siRNA knockdown by renal ultrasound-directed delivery; Na+-K+-ATPase activity assay; co-immunoprecipitation; point mutation of AdipoR1 phosphorylation site","journal":"Clinical science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic and siRNA KD with functional rescue, co-IP for interaction, point mutation evidence, single lab","pmids":["32940654"],"is_preprint":false},{"year":2020,"finding":"GRK4 co-localizes and co-immunoprecipitates with the endothelin receptor type B (ETBR) in renal proximal tubule cells. Hyperphosphorylation of ETBR by GRK4 (as in SHR or GRK4γ 142V transgenic mice) impairs ETBR-mediated natriuresis and diuresis. siRNA knockdown of GRK4 restores inhibitory ETBR effect on Na+-K+-ATPase activity in SHR RPT cells.","method":"Co-immunoprecipitation; confocal colocalization; transgenic mouse model (GRK4γ 142V); ultrasound-targeted siRNA delivery; Na+-K+-ATPase activity assay; receptor phosphorylation assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP interaction, transgenic and siRNA in vivo models, enzymatic activity readout, single lab with multiple methods","pmids":["32687659"],"is_preprint":false},{"year":2023,"finding":"GRK4 co-localizes and co-immunoprecipitates with the renal gastrin receptor (CCKBR) in renal proximal tubule cells. GRK4 phosphorylates CCKBR; siRNA-mediated GRK4 knockdown reduces CCKBR phosphorylation and restores gastrin-mediated inhibition of Na+-K+-ATPase activity in SHR RPT cells.","method":"Co-immunoprecipitation; laser confocal microscopy; siRNA knockdown; Na+-K+-ATPase activity assay; GRK4 A142V transgenic mice","journal":"Clinical and experimental hypertension","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP establishing interaction, siRNA KD with enzymatic functional rescue, transgenic mouse model, single lab","pmids":["37641972"],"is_preprint":false},{"year":2023,"finding":"GRK4 phosphorylates and desensitizes the dopamine D1 receptor (D1R) in skeletal muscle, contributing to insulin resistance. In T2DM mice, GRK4 expression is increased (via ROS/c-Myc pathway), D1R phosphorylation is elevated, and insulin sensitivity is impaired. GRK4 transgenic mice show higher D1R phosphorylation and lower insulin sensitivity; AAV9-shGRK4 knockdown increases insulin sensitivity.","method":"GRK4 transgenic mouse model; AAV9-shRNA knockdown; receptor phosphorylation assay; glucose/insulin tolerance tests; pharmacological D1R agonism/antagonism","journal":"Clinical science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic and viral KD models with functional metabolic readouts, mechanistic pathway validation (ROS/c-Myc/GRK4), single lab","pmids":["37622333"],"is_preprint":false},{"year":2025,"finding":"GRK4 binds to M3 muscarinic acetylcholine receptor (M3-mAChR), increases its phosphorylation, and thereby impedes the M3-mAChR/Cx43 association, leading to connexin43 (Cx43) downregulation and redistribution in cardiomyocytes, increasing susceptibility to ventricular arrhythmias after myocardial infarction. GRK4 mRNA stability is enhanced by METTL3-mediated m6A modification via YTHDF1, increasing GRK4 expression in ischemic hearts.","method":"siRNA/adenovirus overexpression of GRK4 in cardiomyocytes under hypoxia; co-immunoprecipitation (GRK4–M3-mAChR; M3-mAChR–Cx43); Western blot; in vivo arrhythmia susceptibility assay; m6A modification analysis","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP establishing GRK4–M3-mAChR interaction, phosphorylation assay, siRNA and OE in cells and in vivo, single lab with multiple orthogonal methods","pmids":["40484036"],"is_preprint":false},{"year":2025,"finding":"In high-salt-fed GRK4 R65L mice, GRK4 interacts with triosephosphate isomerase 1 (TPI1) (identified by immunoprecipitation-mass spectrometry), increasing TPI1 phosphorylation and nuclear translocation, which decreases DHAP levels and increases H3K27ac binding to the Hao2 promoter, elevating renal Hao2-mediated oxidative stress and causing salt-sensitive hypertension.","method":"Immunoprecipitation-mass spectrometry (GRK4–TPI1 interaction); GRK4 R65L transgenic and global overexpression mice; AAV9-mediated renal knockdown; H3K27ac ChIP; DHAP measurement; antioxidant rescue (tempol)","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — IP-MS identifies novel substrate/interactor, multiple transgenic/KD models, ChIP and metabolite validation, single lab","pmids":["41407053"],"is_preprint":false},{"year":2025,"finding":"PM2.5 upregulates renal GRK4 expression via promoter hypomethylation. GRK4 interacts with and phosphorylates Nedd4L (ubiquitin ligase); phosphorylated Nedd4L reduces ENaC ubiquitination, leading to ENaC accumulation and increased sodium reabsorption. GRK4 knockdown attenuates this effect.","method":"Co-immunoprecipitation (GRK4–Nedd4L); Western blot; promoter methylation assay; lentiviral GRK4 overexpression/knockdown; ENaC ubiquitination assay","journal":"Blood pressure","confidence":"Low","confidence_rationale":"Tier 3 / Weak — co-IP establishing GRK4–Nedd4L interaction with functional downstream evidence, but single lab and abstract-level description limits full assessment","pmids":["41351606"],"is_preprint":false},{"year":2025,"finding":"Omentin-1 suppresses GRK4 expression via the ROS/c-Myc signaling pathway in the kidney; GRK4 overexpression abolishes omentin-1's antihypertensive effects, confirming GRK4 as a downstream mediator of the ROS/c-Myc/GRK4/AT1R axis in salt-sensitive hypertension.","method":"GRK4 overexpression rescue experiment; Western blot; DOCA-salt hypertensive rat model; pharmacological ROS manipulation","journal":"Biochemical pharmacology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — rescue experiment with GRK4 OE places it in pathway, but single lab, single method per step, abstract only","pmids":["41161545"],"is_preprint":false}],"current_model":"GRK4 is a palmitoylated, constitutively active serine/threonine kinase that phosphorylates and desensitizes multiple GPCRs (including dopamine D1R, D3R, mGlu1, GABA(B), ETBR, CCKBR, M3-mAChR, and adiponectin receptor) in a receptor- and isoform-specific manner; it can also mediate phosphorylation-independent desensitization (GABA(B)); GRK4alpha activity is inhibited by Ca2+/calmodulin; GRK4 expression is transcriptionally regulated by the c-Myc pathway (downstream of AT1R/ROS/angiotensin II) and post-transcriptionally repressed by FMRP; in the kidney, hyperactive GRK4 (particularly variants R65L, A142V, A486V) impairs renal sodium excretion by desensitizing natriuretic receptors while enhancing AT1R expression via NF-κB, contributing to salt-sensitive hypertension; in the heart, GRK4 promotes arrhythmia susceptibility by phosphorylating M3-mAChR and disrupting its association with connexin43."},"narrative":{"mechanistic_narrative":"GRK4 is a palmitoylated G protein-coupled receptor kinase that phosphorylates agonist-occupied GPCRs to drive their desensitization, established initially against the purified beta2-adrenergic receptor and luteinizing hormone/chorionic gonadotropin receptor [PMID:8626439]. It exists as multiple splice isoforms with distinct properties: GRK4alpha is uniquely inhibited by direct Ca2+/calmodulin binding (IC50 ~80 nM), whereas the beta, gamma, and delta isoforms do not bind calmodulin, and the isoforms differ in tissue distribution between testis and renal outer medulla [PMID:9092566, PMID:9607785]. Across neuronal systems GRK4 desensitizes the mGlu1 metabotropic glutamate receptor in Purkinje cells via kinase-dependent phosphorylation [PMID:11099476] and the heterodimeric GABA(B) receptor through a phosphorylation-independent mechanism requiring direct complex formation with the GB2 subunit and agonist-triggered translocation to the plasma membrane [PMID:12881416, PMID:17013811]. In the kidney, GRK4 acts as a central regulator of sodium handling by phosphorylating and uncoupling natriuretic receptors—dopamine D3R, adiponectin receptor-1, endothelin receptor type B, and the gastrin receptor CCKBR—from their G proteins, thereby impairing sodium excretion [PMID:19520868, PMID:32940654, PMID:32687659, PMID:37641972]. GRK4 simultaneously enhances pressor signaling: it interacts with AT1R, and the hyperactive GRK4gamma A142V variant increases AT1R expression through the NF-kappaB pathway to potentiate angiotensin II-mediated vasoconstriction [PMID:24218433]. GRK4 expression is itself controlled transcriptionally by c-Myc downstream of AT1R signaling, which uncouples D1R from adenylyl cyclase, and post-transcriptionally repressed by FMRP binding to GRK4 mRNA in cerebellum [PMID:23509080, PMID:26250109]. Beyond receptor desensitization, GRK4 phosphorylates non-receptor substrates including TPI1 and Nedd4L to drive renal oxidative stress and ENaC-dependent sodium reabsorption [PMID:41407053], and in cardiomyocytes it phosphorylates M3-mAChR to disrupt its association with connexin43, increasing post-infarction arrhythmia susceptibility [PMID:40484036].","teleology":[{"year":1996,"claim":"Establishing whether GRK4 is a catalytically functional receptor kinase and how it is membrane-targeted defined its basic biochemical identity.","evidence":"In vitro kinase assay against purified beta2-adrenergic receptor, [3H]palmitate labeling of all four splice variants, and receptor desensitization upon coexpression in HEK293 cells","pmids":["8626439"],"confidence":"High","gaps":["Physiological substrates beyond model receptors not yet identified","Functional consequence of palmitoylation for localization untested"]},{"year":1997,"claim":"Determining isoform-specific catalytic and regulatory differences explained why GRK4 splice variants behave differently, particularly the unique Ca2+/calmodulin inhibition of GRK4alpha.","evidence":"Rhodopsin phosphorylation assays comparing isoforms, CaM-Sepharose pulldown, and ultrastructural localization in spermatozoa","pmids":["9092566"],"confidence":"High","gaps":["Physiological role of calmodulin inhibition in sperm or other tissues unclear","Structural basis of GRK4alpha-specific calmodulin binding not resolved"]},{"year":1998,"claim":"Mapping isoform tissue distribution placed GRK4 catalytic activity in defined cellular contexts (spermatocytes vs renal outer medulla).","evidence":"Rhodopsin phosphorylation assay, in situ hybridization, and quantitative RT-PCR in rat tissues","pmids":["9607785"],"confidence":"Medium","gaps":["Functional substrate in each tissue not identified","Human isoform distribution may differ from rat"]},{"year":2000,"claim":"Identifying mGlu1 as a GRK4 substrate in Purkinje cells demonstrated a kinase-dependent physiological desensitization role in neurons.","evidence":"Phosphorylation assay, antisense knockdown in primary Purkinje cells with desensitization rescue, and confocal colocalization upon agonist exposure","pmids":["11099476"],"confidence":"High","gaps":["Phosphorylation sites on mGlu1 not mapped","Isoform responsible not defined"]},{"year":2003,"claim":"Discovery of phosphorylation-independent GABA(B) desensitization revealed that GRK4 can act as a scaffold/adaptor, not only a kinase.","evidence":"siRNA knockdown in cerebellar granule cells with transfection rescue and kinase-domain-deleted mutants retaining activity","pmids":["12881416"],"confidence":"High","gaps":["Mechanism of kinase-independent desensitization not defined at the molecular level","Domain mediating effect not pinpointed in this study"]},{"year":2004,"claim":"Showing GRK4 does not bind Galphaq distinguished its regulatory repertoire from GRK2, clarifying which signaling modules it does not intercept.","evidence":"In vitro binding and cell-based Galphaq signaling assays using GRK N-terminal constructs","pmids":["15488187"],"confidence":"Medium","gaps":["Negative result; other G protein interactions not surveyed"]},{"year":2007,"claim":"Resolving the direct GRK4-GB2 complex and agonist-triggered membrane translocation provided the physical basis for the earlier phosphorylation-independent GABA(B) effect.","evidence":"Reciprocal FRET and co-IP, live-cell translocation imaging, and Xenopus oocyte electrophysiology","pmids":["17013811"],"confidence":"High","gaps":["Structural interface of GRK4-GB2 not determined","Trigger for cytosol-to-membrane translocation not defined"]},{"year":2009,"claim":"Linking GRK4 to dopamine D3R desensitization in renal proximal tubule established its role in the dopaminergic control of sodium handling.","evidence":"Reciprocal co-IP, BiFC interaction, RNAi knockdown with signaling/mitogenesis readouts, and isoform-specific phosphorylation in human RPT cells and rat kidney","pmids":["19520868"],"confidence":"High","gaps":["D3R phosphorylation sites not mapped","Relative in vivo contribution of GRK4-gamma vs -alpha unclear"]},{"year":2013,"claim":"Defining the AT1R axis and c-Myc transcriptional control showed GRK4 both responds to and amplifies pressor signaling, mechanistically connecting GRK4 variants to hypertension.","evidence":"Co-IP, NF-kappaB ChIP/reporter, GRK4gamma 142V transgenic mice, calcium imaging, and ChIP for c-Myc at the GRK4 promoter with pharmacological rescue","pmids":["24218433","23509080"],"confidence":"High","gaps":["Whether variant effects on AT1R are kinase-dependent not fully resolved","Human genetic causality not established by these mechanistic studies"]},{"year":2015,"claim":"Identifying FMRP-mediated translational repression and agonist-independent phosphorylation by the GRK4 subfamily expanded the regulatory and catalytic understanding of GRK4.","evidence":"In vitro/in vivo RNA binding (RIP) and Fmr1-null cerebellum protein/mRNA discordance; in vitro phosphorylation of inactive receptors using GRK5/6 as subfamily proxies","pmids":["26250109","25770216"],"confidence":"Medium","gaps":["GRK4 itself not directly tested for inactive-receptor phosphorylation","Physiological relevance of FMRP repression outside cerebellum unknown"]},{"year":2023,"claim":"Extending GRK4 desensitization to AdipoR1, ETBR, CCKBR, and skeletal-muscle D1R generalized its role across natriuretic and metabolic receptors.","evidence":"Co-IP and confocal colocalization, GRK4 transgenic and siRNA/AAV knockdown models, Na+-K+-ATPase activity assays, and metabolic tolerance tests","pmids":["32940654","32687659","37641972","37622333"],"confidence":"Medium","gaps":["Receptor phosphorylation sites largely unmapped","Most evidence from a single lab's transgenic models"]},{"year":2025,"claim":"Discovery of non-receptor substrates (TPI1, Nedd4L) and the cardiac M3-mAChR/Cx43 axis broadened GRK4 function beyond GPCR desensitization into metabolic, ion-transport, and arrhythmic mechanisms.","evidence":"IP-MS, co-IP, transgenic/knockdown mouse and cardiomyocyte models, H3K27ac ChIP, ENaC ubiquitination assays, and arrhythmia susceptibility testing","pmids":["41407053","40484036","41351606"],"confidence":"Medium","gaps":["Direct phosphorylation of TPI1/Nedd4L/M3-mAChR sites needs mapping","Nedd4L finding is low-confidence and single-lab","Generalizability beyond disease models untested"]},{"year":null,"claim":"How GRK4 isoform selection, palmitoylation, and translocation are coordinated to choose between kinase-dependent and kinase-independent desensitization across its many receptor and non-receptor substrates remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of GRK4 with any substrate","Determinants of substrate selectivity among isoforms unknown","In vivo phosphosite maps for most substrates absent"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,4,8,9,13,14,15,16,17,18,19]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,4,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,7]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,8,9]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,5,8,9]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[13,14,15,19]}],"complexes":[],"partners":["GB2 (GABBR2)","DRD3","AGTR1","ADIPOR1","EDNRB","CCKBR","CHRM3","NEDD4L"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P32298","full_name":"G protein-coupled receptor kinase 4","aliases":["G protein-coupled receptor kinase GRK4","ITI1"],"length_aa":578,"mass_kda":66.6,"function":"Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2","subcellular_location":"Cytoplasm; Cytoplasm, cell cortex","url":"https://www.uniprot.org/uniprotkb/P32298/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GRK4","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GRK4","total_profiled":1310},"omim":[{"mim_id":"600870","title":"G PROTEIN-COUPLED RECEPTOR KINASE 5; GRK5","url":"https://www.omim.org/entry/600870"},{"mim_id":"137026","title":"G PROTEIN-COUPLED RECEPTOR KINASE 4; GRK4","url":"https://www.omim.org/entry/137026"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Calyx","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"testis","ntpm":39.6}],"url":"https://www.proteinatlas.org/search/GRK4"},"hgnc":{"alias_symbol":["GPRK4"],"prev_symbol":["GPRK2L"]},"alphafold":{"accession":"P32298","domains":[{"cath_id":"3.30.200.20","chopping":"4-18_182-269_490-504","consensus_level":"high","plddt":93.9003,"start":4,"end":504},{"cath_id":"1.10.167.10","chopping":"40-180","consensus_level":"high","plddt":93.6648,"start":40,"end":180},{"cath_id":"1.10.510.10","chopping":"271-468","consensus_level":"high","plddt":95.8527,"start":271,"end":468}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P32298","model_url":"https://alphafold.ebi.ac.uk/files/AF-P32298-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P32298-F1-predicted_aligned_error_v6.png","plddt_mean":88.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GRK4","jax_strain_url":"https://www.jax.org/strain/search?query=GRK4"},"sequence":{"accession":"P32298","fasta_url":"https://rest.uniprot.org/uniprotkb/P32298.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P32298/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P32298"}},"corpus_meta":[{"pmid":"8626439","id":"PMC_8626439","title":"Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626439","citation_count":160,"is_preprint":false},{"pmid":"11099476","id":"PMC_11099476","title":"The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1.","date":"2000","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11099476","citation_count":115,"is_preprint":false},{"pmid":"12881416","id":"PMC_12881416","title":"Phosphorylation-independent desensitization of GABA(B) receptor by GRK4.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12881416","citation_count":100,"is_preprint":false},{"pmid":"9092566","id":"PMC_9092566","title":"G protein-coupled receptor kinase GRK4. Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9092566","citation_count":80,"is_preprint":false},{"pmid":"17066056","id":"PMC_17066056","title":"Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity.","date":"2006","source":"Nature clinical practice. Nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/17066056","citation_count":73,"is_preprint":false},{"pmid":"10506199","id":"PMC_10506199","title":"The GRK4 subfamily of G protein-coupled receptor kinases. Alternative splicing, gene organization, and sequence conservation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10506199","citation_count":70,"is_preprint":false},{"pmid":"19520868","id":"PMC_19520868","title":"G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19520868","citation_count":55,"is_preprint":false},{"pmid":"25770216","id":"PMC_25770216","title":"G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs).","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25770216","citation_count":51,"is_preprint":false},{"pmid":"18413491","id":"PMC_18413491","title":"Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4.","date":"2008","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/18413491","citation_count":50,"is_preprint":false},{"pmid":"9607785","id":"PMC_9607785","title":"Rat G protein-coupled receptor kinase GRK4: identification, functional expression, and differential tissue distribution of two splice variants.","date":"1998","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9607785","citation_count":48,"is_preprint":false},{"pmid":"9495886","id":"PMC_9495886","title":"Sequestration of human muscarinic acetylcholine receptor hm1-hm5 subtypes: effect of G protein-coupled receptor kinases GRK2, GRK4, GRK5 and GRK6.","date":"1998","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/9495886","citation_count":44,"is_preprint":false},{"pmid":"24218433","id":"PMC_24218433","title":"Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/24218433","citation_count":41,"is_preprint":false},{"pmid":"16441255","id":"PMC_16441255","title":"Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure.","date":"2006","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16441255","citation_count":41,"is_preprint":false},{"pmid":"22123211","id":"PMC_22123211","title":"Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.","date":"2012","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/22123211","citation_count":38,"is_preprint":false},{"pmid":"17013811","id":"PMC_17013811","title":"Desensitization of GABA(B) receptor signaling by formation of protein complexes of GABA(B2) subunit with GRK4 or GRK5.","date":"2007","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17013811","citation_count":32,"is_preprint":false},{"pmid":"25775155","id":"PMC_25775155","title":"The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25775155","citation_count":27,"is_preprint":false},{"pmid":"22639547","id":"PMC_22639547","title":"Pooled analyses of the associations of polymorphisms in the GRK4 and EMILIN1 genes with hypertension risk.","date":"2012","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22639547","citation_count":21,"is_preprint":false},{"pmid":"26250109","id":"PMC_26250109","title":"The FMRP/GRK4 mRNA interaction uncovers a new mode of binding of the Fragile X mental retardation protein in cerebellum.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26250109","citation_count":20,"is_preprint":false},{"pmid":"26730182","id":"PMC_26730182","title":"Association between GRK4 and DRD1 gene polymorphisms and hypertension: a meta-analysis.","date":"2015","source":"Clinical interventions in aging","url":"https://pubmed.ncbi.nlm.nih.gov/26730182","citation_count":18,"is_preprint":false},{"pmid":"32940654","id":"PMC_32940654","title":"GRK4-mediated adiponectin receptor-1 phosphorylative desensitization as a novel mechanism of reduced renal sodium excretion in hypertension.","date":"2020","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/32940654","citation_count":17,"is_preprint":false},{"pmid":"35487286","id":"PMC_35487286","title":"Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics.","date":"2022","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35487286","citation_count":16,"is_preprint":false},{"pmid":"23509080","id":"PMC_23509080","title":"A novel role for c-Myc in G protein-coupled receptor kinase 4 (GRK4) transcriptional regulation in human kidney proximal tubule cells.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/23509080","citation_count":13,"is_preprint":false},{"pmid":"33127268","id":"PMC_33127268","title":"Associations of SUCNR1, GRK4, CAMK1D gene polymorphisms and the susceptibility of type 2 diabetes mellitus and essential hypertension in a northern Chinese Han population.","date":"2020","source":"Journal of diabetes and its complications","url":"https://pubmed.ncbi.nlm.nih.gov/33127268","citation_count":12,"is_preprint":false},{"pmid":"32687659","id":"PMC_32687659","title":"Role of GRK4 in the regulation of the renal ETB receptor in hypertension.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32687659","citation_count":10,"is_preprint":false},{"pmid":"36552750","id":"PMC_36552750","title":"LncRNA 148400 Promotes the Apoptosis of Renal Tubular Epithelial Cells in Ischemic AKI by Targeting the miR-10b-3p/GRK4 Axis.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36552750","citation_count":9,"is_preprint":false},{"pmid":"37009199","id":"PMC_37009199","title":"Dopamine Receptor D1R and D3R and GRK4 Interaction in Hypertension.","date":"2023","source":"The Yale journal of biology and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37009199","citation_count":7,"is_preprint":false},{"pmid":"38365112","id":"PMC_38365112","title":"Exosomal miR-122-3p represses the growth and metastasis of MCF-7/ADR cells by targeting GRK4-mediated activation of the Wnt/β-catenin pathway.","date":"2024","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/38365112","citation_count":7,"is_preprint":false},{"pmid":"15488187","id":"PMC_15488187","title":"Analysis of differential modulatory activities of GRK2 and GRK4 on Galphaq-coupled receptor signaling.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488187","citation_count":7,"is_preprint":false},{"pmid":"37622333","id":"PMC_37622333","title":"Exercise ameliorates skeletal muscle insulin resistance by modulating GRK4-mediated D1R expression.","date":"2023","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/37622333","citation_count":5,"is_preprint":false},{"pmid":"33899625","id":"PMC_33899625","title":"Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.","date":"2021","source":"Clinical and experimental hypertension (New York, N.Y. : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/33899625","citation_count":5,"is_preprint":false},{"pmid":"37994311","id":"PMC_37994311","title":"GRK4, A Potential Link between Hypertension and Breast Cancer.","date":"2022","source":"Journal of cell science & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37994311","citation_count":3,"is_preprint":false},{"pmid":"34297769","id":"PMC_34297769","title":"Targeted capture sequencing identifies genetic variations of GRK4 and RDH8 in Han Chinese with essential hypertension in Xinjiang.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34297769","citation_count":3,"is_preprint":false},{"pmid":"37641972","id":"PMC_37641972","title":"Effect of GRK4 on renal gastrin receptor regulation in hypertension.","date":"2023","source":"Clinical and experimental hypertension (New York, N.Y. : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/37641972","citation_count":2,"is_preprint":false},{"pmid":"40484036","id":"PMC_40484036","title":"Inhibition of GRK4 reduces arrhythmia susceptibility and alleviates connexin43 dysregulation after myocardial infarction.","date":"2025","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40484036","citation_count":1,"is_preprint":false},{"pmid":"38471134","id":"PMC_38471134","title":"Chronic exercise improves renal AT1 and ETB receptor functions via modulating GRK4 expression in obese Zucker rats.","date":"2024","source":"Clinical and experimental hypertension (New York, N.Y. : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/38471134","citation_count":1,"is_preprint":false},{"pmid":"39558015","id":"PMC_39558015","title":"A cross-tissue transcriptome-wide association study reveals GRK4 as a novel susceptibility gene for COPD.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39558015","citation_count":1,"is_preprint":false},{"pmid":"41407053","id":"PMC_41407053","title":"GRK4 R65L causes salt-sensitive hypertension by augmenting renal Hao2-mediated oxidative stress via increasing the phosphorylation of TPI1 and promoting H3K27ac expression.","date":"2025","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41407053","citation_count":0,"is_preprint":false},{"pmid":"41351606","id":"PMC_41351606","title":"PM2.5-induced hypertension via renal GRK4/Nedd4L/ENaC axis: epigenetic and post-translational mechanisms.","date":"2025","source":"Blood pressure","url":"https://pubmed.ncbi.nlm.nih.gov/41351606","citation_count":0,"is_preprint":false},{"pmid":"41161545","id":"PMC_41161545","title":"Omentin-1 attenuates salt-sensitive hypertension via GRK4/AT1R downregulation mediated by the ROS/c-Myc pathway.","date":"2025","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41161545","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23393,"output_tokens":6173,"usd":0.081387,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14710,"output_tokens":4324,"usd":0.090825,"stage2_stop_reason":"end_turn"},"total_usd":0.172212,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"GRK4 is a functional protein kinase capable of phosphorylating agonist-occupied, purified beta2-adrenergic receptor in vitro, and all four splice variants incorporate [3H]palmitate (palmitoylation). GRK4 augments desensitization of the rat luteinizing hormone/chorionic gonadotropin receptor upon coexpression in HEK293 cells.\",\n      \"method\": \"In vitro kinase assay with purified beta2-adrenergic receptor; [3H]palmitate incorporation; coexpression in HEK293 cells with functional desensitization readout\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus receptor desensitization in cells, multiple isoforms tested, original characterization paper\",\n      \"pmids\": [\"8626439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"GRK4alpha, but not GRK4beta, -gamma, or -delta, phosphorylates rhodopsin in an agonist-dependent manner. GRK4alpha kinase activity is inhibited by Ca2+/calmodulin (IC50 ~80 nM) via a direct interaction; the other three isoforms do not interact with calmodulin. GRK4gamma is the only detectable isoform in human sperm. GRK4 is localized to acrosomal membranes and outer mitochondrial membranes of spermatozoa.\",\n      \"method\": \"Rhodopsin phosphorylation assay; CaM-Sepharose 4B pulldown; immunochemical and ultrastructural (electron microscopy) localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay with isoform-specific comparisons, direct binding pulldown, structural localization by electron microscopy, multiple orthogonal methods\",\n      \"pmids\": [\"9092566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rat GRK4A and GRK4B are both functional protein kinases, as demonstrated by rhodopsin phosphorylation. GRK4A mRNA predominates in leptotene to late pachytene primary spermatocytes and round spermatids; GRK4B mRNA is enriched ~20-fold in renal outer medulla compared to testis, indicating isoform-specific tissue distribution.\",\n      \"method\": \"Rhodopsin phosphorylation assay; in situ hybridization; quantitative RT-PCR\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — kinase activity confirmed by in vitro assay, tissue distribution by two orthogonal methods (ISH + qRT-PCR), single lab\",\n      \"pmids\": [\"9607785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GRK4 delta (but not GRK2) did not significantly facilitate sequestration of muscarinic m1–m5 receptors in COS-7 cells, with the partial exception that GRK4 delta tended to facilitate m2 receptor sequestration. In BHK-21 cells, GRK4 delta facilitated sequestration of m2 but not m3 receptors.\",\n      \"method\": \"Radioligand binding ([3H]N-methylscopolamine) sequestration assay in COS-7 and BHK-21 cells with GRK coexpression\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based receptor sequestration assay with functional readout, multiple receptor subtypes and cell lines tested, single lab\",\n      \"pmids\": [\"9495886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GRK4 mediates homologous desensitization of the mGlu1 metabotropic glutamate receptor in cerebellar Purkinje cells. GRK4 kinase activity is required: agonist-dependent phosphorylation of mGlu1a was demonstrated, and antisense reduction of GRK4 in Purkinje cells impaired receptor desensitization. GRK4 redistributes and colocalizes with mGlu1 receptor upon agonist exposure and internalization.\",\n      \"method\": \"Coexpression in HEK293 cells with functional signaling assay; receptor phosphorylation assay; antisense knockdown in primary Purkinje cells; confocal colocalization imaging\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (phosphorylation assay, antisense KD with phenotypic rescue, colocalization), replicated across heterologous and primary cells\",\n      \"pmids\": [\"11099476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GRK4 mediates agonist-promoted desensitization of the heterodimeric GABA(B) receptor in cerebellar granule cells via a phosphorylation-independent mechanism. siRNA knockdown of GRK4 strongly inhibited desensitization; GRK4 mutants deleted of their kinase domain could still promote desensitization; no ligand-induced receptor phosphorylation was detected.\",\n      \"method\": \"siRNA knockdown in cerebellar granule cells; transfection of kinase-dead/domain-deleted GRK4 mutants in HEK293 cells; functional desensitization assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — siRNA KD with rescue by transfection, domain-deletion mutagenesis establishing phosphorylation independence, multiple cell systems, orthogonal methods\",\n      \"pmids\": [\"12881416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GRK4, unlike GRK2, does not interact with Galphaq (neither in vitro nor in cells) and therefore does not inhibit Galphaq-dependent signaling, distinguishing the modulatory activities of these two kinase subfamilies.\",\n      \"method\": \"In vitro binding assay; cell-based signaling assay measuring Galphaq-dependent activity with GRK N-terminal domain constructs\",\n      \"journal\": \"Methods in enzymology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro binding and cell-based assay, mechanistically informative negative result for GRK4/Galphaq interaction, single lab\",\n      \"pmids\": [\"15488187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GRK4 desensitizes GABA(B) receptor-mediated signaling by forming a direct protein complex with the GB2 subunit at the plasma membrane. Upon GABA(B) receptor activation, GRK4 translocates from cytosol to plasma membrane. FRET analysis and co-immunoprecipitation confirmed GRK4–GB2R complex formation. GRK5 also forms this complex; GRK2, GRK3, and GRK6 do not.\",\n      \"method\": \"FRET (GRK4-Cerulean / GB2R-Venus); co-immunoprecipitation/Western blot; live-cell imaging of GRK4 translocation; Xenopus oocyte electrophysiology; BHK cell transfection\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reciprocal FRET + co-IP confirming complex, translocation imaging, functional electrophysiology, multiple orthogonal methods in same study\",\n      \"pmids\": [\"17013811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GRK4 (specifically GRK4-gamma and GRK4-alpha isoforms) co-immunoprecipitates and co-localizes with the dopamine D3 receptor in human proximal tubule cells and rat kidney. Agonist activation initiates GRK4–D3R interaction at the cell membrane and promotes it intracellularly. GRK4-gamma and GRK4-alpha mediate 3- and 2-fold increases in phosphorylation of agonist-activated D3R, respectively. GRK4 knockdown abolished D3R-stimulated p44/42 phosphorylation and mitogenesis.\",\n      \"method\": \"Co-immunoprecipitation; bimolecular fluorescence complementation (BiFC) + confocal microscopy; RNAi knockdown; kinase activity inhibition with heparin; receptor phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, BiFC interaction assay, RNAi KD with signaling readout, isoform-specific phosphorylation, multiple orthogonal methods\",\n      \"pmids\": [\"19520868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GRK4 interacts directly with the angiotensin II type 1 receptor (AT1R) in vascular smooth muscle cells. The GRK4gamma A142V variant increases AT1R mRNA and protein expression via the NF-κB pathway (with greater NF-κB binding to the AT1R promoter), decreases AT1R phosphorylation (reducing degradation), and enhances AT1R-mediated intracellular calcium responses and angiotensin II-mediated vasoconstriction in transgenic mice.\",\n      \"method\": \"Co-immunoprecipitation; heterologous expression of GRK4γ 142V in A10 cells; NF-κB reporter/ChIP assay; calcium imaging; transgenic mouse model; aortic vasoconstriction assay\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP establishing interaction, NF-κB ChIP, transgenic mouse validation, multiple orthogonal methods across cell and animal models\",\n      \"pmids\": [\"24218433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The transcription factor c-Myc binds the GRK4 promoter and positively regulates GRK4 protein expression in human renal proximal tubule cells. Angiotensin II (via AT1R) increases phospho-c-Myc and subsequently GRK4 expression, which then uncouples D1R from adenylyl cyclase. c-Myc inhibitor 10074-G5 or AT1R blockade with losartan restored D1R coupling.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for c-Myc at GRK4 promoter; pharmacological inhibition; Western blot for phospho-c-Myc and GRK4; adenylyl cyclase coupling assay\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating c-Myc binding to GRK4 promoter, pharmacological rescue, single lab with two orthogonal methods\",\n      \"pmids\": [\"23509080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FMRP (Fragile X Mental Retardation Protein) binds GRK4 mRNA via a specific stem-loop domain (G4RIF) in the 3' region through its C-terminal domain, and negatively regulates GRK4 translation in cerebellum. GRK4 protein (but not mRNA) is increased in Fmr1-null cerebellum, indicating translational repression.\",\n      \"method\": \"In vitro RNA binding assay; in vivo RIP (RNA immunoprecipitation); Western blot and qPCR in Fmr1 knockout mouse cerebellum; reporter assay with G4RIF domain\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo binding confirmed, protein/mRNA discordance in KO tissue, single lab with two orthogonal methods\",\n      \"pmids\": [\"26250109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GRK4 subfamily members (GRK5/6, closely related to GRK4) phosphorylate inactive (unactivated) GPCRs, including beta2-adrenergic and M2 muscarinic receptors, in an agonist-independent manner, and this phosphorylation enhances arrestin recruitment. GRK4 subfamily differs from GRK2/3 subfamily in this respect.\",\n      \"method\": \"In vitro phosphorylation assay; arrestin recruitment assay; mutagenesis to exclude constitutive receptor activity; membrane-association controls\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro assay with mutagenesis controls, but GRK4 itself was not directly tested (GRK5/6 as proxies), single lab\",\n      \"pmids\": [\"25770216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRK4 phosphorylates and desensitizes the adiponectin receptor-1 (AdipoR1) in renal proximal tubule cells, uncoupling it from Gαi and impairing adiponectin-mediated inhibition of Na+-K+-ATPase activity. GRK4 transgenic (hyperphosphorylating variant) mice replicate impaired adiponectin-mediated natriuresis; siRNA-mediated GRK4 knockdown in SHR restores adiponectin-mediated sodium excretion.\",\n      \"method\": \"GRK4 transgenic mouse model; siRNA knockdown by renal ultrasound-directed delivery; Na+-K+-ATPase activity assay; co-immunoprecipitation; point mutation of AdipoR1 phosphorylation site\",\n      \"journal\": \"Clinical science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic and siRNA KD with functional rescue, co-IP for interaction, point mutation evidence, single lab\",\n      \"pmids\": [\"32940654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRK4 co-localizes and co-immunoprecipitates with the endothelin receptor type B (ETBR) in renal proximal tubule cells. Hyperphosphorylation of ETBR by GRK4 (as in SHR or GRK4γ 142V transgenic mice) impairs ETBR-mediated natriuresis and diuresis. siRNA knockdown of GRK4 restores inhibitory ETBR effect on Na+-K+-ATPase activity in SHR RPT cells.\",\n      \"method\": \"Co-immunoprecipitation; confocal colocalization; transgenic mouse model (GRK4γ 142V); ultrasound-targeted siRNA delivery; Na+-K+-ATPase activity assay; receptor phosphorylation assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP interaction, transgenic and siRNA in vivo models, enzymatic activity readout, single lab with multiple methods\",\n      \"pmids\": [\"32687659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRK4 co-localizes and co-immunoprecipitates with the renal gastrin receptor (CCKBR) in renal proximal tubule cells. GRK4 phosphorylates CCKBR; siRNA-mediated GRK4 knockdown reduces CCKBR phosphorylation and restores gastrin-mediated inhibition of Na+-K+-ATPase activity in SHR RPT cells.\",\n      \"method\": \"Co-immunoprecipitation; laser confocal microscopy; siRNA knockdown; Na+-K+-ATPase activity assay; GRK4 A142V transgenic mice\",\n      \"journal\": \"Clinical and experimental hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP establishing interaction, siRNA KD with enzymatic functional rescue, transgenic mouse model, single lab\",\n      \"pmids\": [\"37641972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRK4 phosphorylates and desensitizes the dopamine D1 receptor (D1R) in skeletal muscle, contributing to insulin resistance. In T2DM mice, GRK4 expression is increased (via ROS/c-Myc pathway), D1R phosphorylation is elevated, and insulin sensitivity is impaired. GRK4 transgenic mice show higher D1R phosphorylation and lower insulin sensitivity; AAV9-shGRK4 knockdown increases insulin sensitivity.\",\n      \"method\": \"GRK4 transgenic mouse model; AAV9-shRNA knockdown; receptor phosphorylation assay; glucose/insulin tolerance tests; pharmacological D1R agonism/antagonism\",\n      \"journal\": \"Clinical science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic and viral KD models with functional metabolic readouts, mechanistic pathway validation (ROS/c-Myc/GRK4), single lab\",\n      \"pmids\": [\"37622333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRK4 binds to M3 muscarinic acetylcholine receptor (M3-mAChR), increases its phosphorylation, and thereby impedes the M3-mAChR/Cx43 association, leading to connexin43 (Cx43) downregulation and redistribution in cardiomyocytes, increasing susceptibility to ventricular arrhythmias after myocardial infarction. GRK4 mRNA stability is enhanced by METTL3-mediated m6A modification via YTHDF1, increasing GRK4 expression in ischemic hearts.\",\n      \"method\": \"siRNA/adenovirus overexpression of GRK4 in cardiomyocytes under hypoxia; co-immunoprecipitation (GRK4–M3-mAChR; M3-mAChR–Cx43); Western blot; in vivo arrhythmia susceptibility assay; m6A modification analysis\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP establishing GRK4–M3-mAChR interaction, phosphorylation assay, siRNA and OE in cells and in vivo, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"40484036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In high-salt-fed GRK4 R65L mice, GRK4 interacts with triosephosphate isomerase 1 (TPI1) (identified by immunoprecipitation-mass spectrometry), increasing TPI1 phosphorylation and nuclear translocation, which decreases DHAP levels and increases H3K27ac binding to the Hao2 promoter, elevating renal Hao2-mediated oxidative stress and causing salt-sensitive hypertension.\",\n      \"method\": \"Immunoprecipitation-mass spectrometry (GRK4–TPI1 interaction); GRK4 R65L transgenic and global overexpression mice; AAV9-mediated renal knockdown; H3K27ac ChIP; DHAP measurement; antioxidant rescue (tempol)\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — IP-MS identifies novel substrate/interactor, multiple transgenic/KD models, ChIP and metabolite validation, single lab\",\n      \"pmids\": [\"41407053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PM2.5 upregulates renal GRK4 expression via promoter hypomethylation. GRK4 interacts with and phosphorylates Nedd4L (ubiquitin ligase); phosphorylated Nedd4L reduces ENaC ubiquitination, leading to ENaC accumulation and increased sodium reabsorption. GRK4 knockdown attenuates this effect.\",\n      \"method\": \"Co-immunoprecipitation (GRK4–Nedd4L); Western blot; promoter methylation assay; lentiviral GRK4 overexpression/knockdown; ENaC ubiquitination assay\",\n      \"journal\": \"Blood pressure\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — co-IP establishing GRK4–Nedd4L interaction with functional downstream evidence, but single lab and abstract-level description limits full assessment\",\n      \"pmids\": [\"41351606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Omentin-1 suppresses GRK4 expression via the ROS/c-Myc signaling pathway in the kidney; GRK4 overexpression abolishes omentin-1's antihypertensive effects, confirming GRK4 as a downstream mediator of the ROS/c-Myc/GRK4/AT1R axis in salt-sensitive hypertension.\",\n      \"method\": \"GRK4 overexpression rescue experiment; Western blot; DOCA-salt hypertensive rat model; pharmacological ROS manipulation\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — rescue experiment with GRK4 OE places it in pathway, but single lab, single method per step, abstract only\",\n      \"pmids\": [\"41161545\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GRK4 is a palmitoylated, constitutively active serine/threonine kinase that phosphorylates and desensitizes multiple GPCRs (including dopamine D1R, D3R, mGlu1, GABA(B), ETBR, CCKBR, M3-mAChR, and adiponectin receptor) in a receptor- and isoform-specific manner; it can also mediate phosphorylation-independent desensitization (GABA(B)); GRK4alpha activity is inhibited by Ca2+/calmodulin; GRK4 expression is transcriptionally regulated by the c-Myc pathway (downstream of AT1R/ROS/angiotensin II) and post-transcriptionally repressed by FMRP; in the kidney, hyperactive GRK4 (particularly variants R65L, A142V, A486V) impairs renal sodium excretion by desensitizing natriuretic receptors while enhancing AT1R expression via NF-κB, contributing to salt-sensitive hypertension; in the heart, GRK4 promotes arrhythmia susceptibility by phosphorylating M3-mAChR and disrupting its association with connexin43.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GRK4 is a palmitoylated G protein-coupled receptor kinase that phosphorylates agonist-occupied GPCRs to drive their desensitization, established initially against the purified beta2-adrenergic receptor and luteinizing hormone/chorionic gonadotropin receptor [#0]. It exists as multiple splice isoforms with distinct properties: GRK4alpha is uniquely inhibited by direct Ca2+/calmodulin binding (IC50 ~80 nM), whereas the beta, gamma, and delta isoforms do not bind calmodulin, and the isoforms differ in tissue distribution between testis and renal outer medulla [#1, #2]. Across neuronal systems GRK4 desensitizes the mGlu1 metabotropic glutamate receptor in Purkinje cells via kinase-dependent phosphorylation [#4] and the heterodimeric GABA(B) receptor through a phosphorylation-independent mechanism requiring direct complex formation with the GB2 subunit and agonist-triggered translocation to the plasma membrane [#5, #7]. In the kidney, GRK4 acts as a central regulator of sodium handling by phosphorylating and uncoupling natriuretic receptors—dopamine D3R, adiponectin receptor-1, endothelin receptor type B, and the gastrin receptor CCKBR—from their G proteins, thereby impairing sodium excretion [#8, #13, #14, #15]. GRK4 simultaneously enhances pressor signaling: it interacts with AT1R, and the hyperactive GRK4gamma A142V variant increases AT1R expression through the NF-kappaB pathway to potentiate angiotensin II-mediated vasoconstriction [#9]. GRK4 expression is itself controlled transcriptionally by c-Myc downstream of AT1R signaling, which uncouples D1R from adenylyl cyclase, and post-transcriptionally repressed by FMRP binding to GRK4 mRNA in cerebellum [#10, #11]. Beyond receptor desensitization, GRK4 phosphorylates non-receptor substrates including TPI1 and Nedd4L to drive renal oxidative stress and ENaC-dependent sodium reabsorption [#18], and in cardiomyocytes it phosphorylates M3-mAChR to disrupt its association with connexin43, increasing post-infarction arrhythmia susceptibility [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing whether GRK4 is a catalytically functional receptor kinase and how it is membrane-targeted defined its basic biochemical identity.\",\n      \"evidence\": \"In vitro kinase assay against purified beta2-adrenergic receptor, [3H]palmitate labeling of all four splice variants, and receptor desensitization upon coexpression in HEK293 cells\",\n      \"pmids\": [\"8626439\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrates beyond model receptors not yet identified\", \"Functional consequence of palmitoylation for localization untested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Determining isoform-specific catalytic and regulatory differences explained why GRK4 splice variants behave differently, particularly the unique Ca2+/calmodulin inhibition of GRK4alpha.\",\n      \"evidence\": \"Rhodopsin phosphorylation assays comparing isoforms, CaM-Sepharose pulldown, and ultrastructural localization in spermatozoa\",\n      \"pmids\": [\"9092566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of calmodulin inhibition in sperm or other tissues unclear\", \"Structural basis of GRK4alpha-specific calmodulin binding not resolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapping isoform tissue distribution placed GRK4 catalytic activity in defined cellular contexts (spermatocytes vs renal outer medulla).\",\n      \"evidence\": \"Rhodopsin phosphorylation assay, in situ hybridization, and quantitative RT-PCR in rat tissues\",\n      \"pmids\": [\"9607785\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional substrate in each tissue not identified\", \"Human isoform distribution may differ from rat\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identifying mGlu1 as a GRK4 substrate in Purkinje cells demonstrated a kinase-dependent physiological desensitization role in neurons.\",\n      \"evidence\": \"Phosphorylation assay, antisense knockdown in primary Purkinje cells with desensitization rescue, and confocal colocalization upon agonist exposure\",\n      \"pmids\": [\"11099476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites on mGlu1 not mapped\", \"Isoform responsible not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Discovery of phosphorylation-independent GABA(B) desensitization revealed that GRK4 can act as a scaffold/adaptor, not only a kinase.\",\n      \"evidence\": \"siRNA knockdown in cerebellar granule cells with transfection rescue and kinase-domain-deleted mutants retaining activity\",\n      \"pmids\": [\"12881416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of kinase-independent desensitization not defined at the molecular level\", \"Domain mediating effect not pinpointed in this study\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showing GRK4 does not bind Galphaq distinguished its regulatory repertoire from GRK2, clarifying which signaling modules it does not intercept.\",\n      \"evidence\": \"In vitro binding and cell-based Galphaq signaling assays using GRK N-terminal constructs\",\n      \"pmids\": [\"15488187\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative result; other G protein interactions not surveyed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolving the direct GRK4-GB2 complex and agonist-triggered membrane translocation provided the physical basis for the earlier phosphorylation-independent GABA(B) effect.\",\n      \"evidence\": \"Reciprocal FRET and co-IP, live-cell translocation imaging, and Xenopus oocyte electrophysiology\",\n      \"pmids\": [\"17013811\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural interface of GRK4-GB2 not determined\", \"Trigger for cytosol-to-membrane translocation not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linking GRK4 to dopamine D3R desensitization in renal proximal tubule established its role in the dopaminergic control of sodium handling.\",\n      \"evidence\": \"Reciprocal co-IP, BiFC interaction, RNAi knockdown with signaling/mitogenesis readouts, and isoform-specific phosphorylation in human RPT cells and rat kidney\",\n      \"pmids\": [\"19520868\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"D3R phosphorylation sites not mapped\", \"Relative in vivo contribution of GRK4-gamma vs -alpha unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defining the AT1R axis and c-Myc transcriptional control showed GRK4 both responds to and amplifies pressor signaling, mechanistically connecting GRK4 variants to hypertension.\",\n      \"evidence\": \"Co-IP, NF-kappaB ChIP/reporter, GRK4gamma 142V transgenic mice, calcium imaging, and ChIP for c-Myc at the GRK4 promoter with pharmacological rescue\",\n      \"pmids\": [\"24218433\", \"23509080\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether variant effects on AT1R are kinase-dependent not fully resolved\", \"Human genetic causality not established by these mechanistic studies\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying FMRP-mediated translational repression and agonist-independent phosphorylation by the GRK4 subfamily expanded the regulatory and catalytic understanding of GRK4.\",\n      \"evidence\": \"In vitro/in vivo RNA binding (RIP) and Fmr1-null cerebellum protein/mRNA discordance; in vitro phosphorylation of inactive receptors using GRK5/6 as subfamily proxies\",\n      \"pmids\": [\"26250109\", \"25770216\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GRK4 itself not directly tested for inactive-receptor phosphorylation\", \"Physiological relevance of FMRP repression outside cerebellum unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extending GRK4 desensitization to AdipoR1, ETBR, CCKBR, and skeletal-muscle D1R generalized its role across natriuretic and metabolic receptors.\",\n      \"evidence\": \"Co-IP and confocal colocalization, GRK4 transgenic and siRNA/AAV knockdown models, Na+-K+-ATPase activity assays, and metabolic tolerance tests\",\n      \"pmids\": [\"32940654\", \"32687659\", \"37641972\", \"37622333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor phosphorylation sites largely unmapped\", \"Most evidence from a single lab's transgenic models\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery of non-receptor substrates (TPI1, Nedd4L) and the cardiac M3-mAChR/Cx43 axis broadened GRK4 function beyond GPCR desensitization into metabolic, ion-transport, and arrhythmic mechanisms.\",\n      \"evidence\": \"IP-MS, co-IP, transgenic/knockdown mouse and cardiomyocyte models, H3K27ac ChIP, ENaC ubiquitination assays, and arrhythmia susceptibility testing\",\n      \"pmids\": [\"41407053\", \"40484036\", \"41351606\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct phosphorylation of TPI1/Nedd4L/M3-mAChR sites needs mapping\", \"Nedd4L finding is low-confidence and single-lab\", \"Generalizability beyond disease models untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GRK4 isoform selection, palmitoylation, and translocation are coordinated to choose between kinase-dependent and kinase-independent desensitization across its many receptor and non-receptor substrates remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of GRK4 with any substrate\", \"Determinants of substrate selectivity among isoforms unknown\", \"In vivo phosphosite maps for most substrates absent\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 4, 8, 9, 13, 14, 15, 16, 17, 18, 19]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 7]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 8, 9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 5, 8, 9]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [13, 14, 15, 19]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GB2 (GABBR2)\", \"DRD3\", \"AGTR1\", \"ADIPOR1\", \"EDNRB\", \"CCKBR\", \"CHRM3\", \"NEDD4L\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":7,"faith_pct":85.71428571428571}}